Home / Market News / $TER
fiscal.ai Corporate Catalyst Impact 65/100 ● positive

UBS Adjusts Teradyne Price Target to $430 From $485

Oct 29, 2026, 6:06 PM UTC · Primary ticker $TER

UBS has lowered its price target for Teradyne shares from $485 to $430, while reiterating a Buy rating. This adjustment follows the company's recent Q3 2026 financial results and updated guidance, indicating a revised valuation perspective from the analyst.

UBS has adjusted its price target for Teradyne (TER) shares downwards from $485 to $430. This change, while still maintaining a 'Buy' rating, reflects a revised valuation based on the company's recently reported third-quarter 2026 financial results and updated guidance. For traders, this indicates that while the long-term outlook remains positive according to UBS, the near-term growth trajectory or valuation multiples may have been tempered. The short-term implication is potential downward pressure on the stock as investors react to the lower price target, despite the maintained 'Buy' rating. The long-term implication depends on whether the underlying business fundamentals justify the revised target and if the company can exceed future expectations.

$TER negative price target reduction
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.